Cargando…
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
Extracellular vesicles (EVs) are cell-derived nanoparticles that facilitate transport of proteins, lipids, and genetic material, playing important roles in intracellular communication. They have remarkable potential as non-toxic and non-immunogenic nanocarriers for drug delivery to unreachable organ...
Autores principales: | Zhao, Yuling, Haney, Matthew J., Fallon, John K., Rodriguez, Myosotys, Swain, Carson J., Arzt, Camryn J., Smith, Philip C., Loop, Matthew Shane, Harrison, Emily B., El-Hage, Nazira, Batrakova, Elena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222008/ https://www.ncbi.nlm.nih.gov/pubmed/35741061 http://dx.doi.org/10.3390/cells11121933 |
Ejemplares similares
-
Extracellular Vesicles Released by Genetically Modified Macrophages Activate Autophagy and Produce Potent Neuroprotection in Mouse Model of Lysosomal Storage Disorder, Batten Disease
por: El-Hage, Nazira, et al.
Publicado: (2023) -
GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014) -
Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
por: Klyachko, Natalia L., et al.
Publicado: (2020) -
Targeting Beclin1 as an Adjunctive Therapy against HIV Using Mannosylated Polyethylenimine Nanoparticles
por: Rodriguez, Myosotys, et al.
Publicado: (2021) -
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
por: Haney, Matthew J., et al.
Publicado: (2020)